Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Invasive iNO for BPD Prevention in Preterms
NCT00955487Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Jan 2007
- Primary completion
- Jul 2014
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in bronchopulmonary dysplasia (BPD), pulmonary hypertension (PH), sponsored by University of Colorado Denver. Started Jan 2007; status: completed.
02
Drugs
nitric oxide
03
Conditions
bronchopulmonary dysplasia (BPD)pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00955487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955487.